Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA expands approval of breast cancer drug Kisqali
FDA expands approval of breast cancer drug Kisqali to earlier-stage patients
The Food and Drug Administration expanded the approval of Kisqali, a drug for metastatic breast cancer, to also treat patients with earlier stages of the disease, drugmaker Novartis said Tuesday.
FDA Expands Use of Breast Cancer Drug Kisqali
While Verzenio, a drug in the same class, has been approved to lower the risk of early breast cancer returning, it's only for people with a very high risk of recurrence. Kisqali will be available to a much broader group of patients, whose disease may not be as aggressive at the time of diagnosis, Novartis said.
FDA OKs Adjuvant Ribociclib in Earlier Stage Breast Cancer
Unlike rival CDK 4/6 inhibitor abemaciclib, patients don't need to be lymph-node positive to receive ribociclib after surgery.
Novartis CEO says FDA's extended approval of breast cancer drug is a 'landmark' for the firm
Vas Narasimhan, CEO of Novartis, comments on the progress of the firm's Kisqali metastatic breast cancer drug after the company recently received an extended approval for it from the U.S. Food and Drug Administration.
Breast cancer drug Kisqali gets FDA approval to prevent cancer recurrence
The breast cancer drug Kisqali has received FDA approval to reduce cases of cancer recurrence. The drug was found to reduce the chances of a patient's breast cancer coming back by 25%.
FDA expanded their approval on drug cancer drug
First News
1d
on MSN
Davis professor loses breast cancer battle months after community rallied to help find innovative therapies
Danielle Heard Mollel first shared her journey with stage 4 breast cancer with CBS13 in April. The Davis professor and mother ...
21h
Breast cancer at 38 left 1 woman weak and vulnerable. How strength training got her in the best shape of her life
Once Cait Lowry finished breast cancer treatment, weight lifting helped her rebuild muscle, boost her energy and fight brain ...
Healthline
20h
Why ‘Get Organized’ Star Clea Shearer Feels ‘Lucky’ After Breast Cancer Treatment
Get Organized with the Home Edit” star Clea Shearer opens up about how she finds new meaning in life two years after being ...
13h
on MSN
Philadelphia breast cancer survivors train for historic rowing competition in Boston
A group of Philadelphia breast cancer survivors are getting ready for a big rowing competition, the first of its kind. These ...
2d
Black Women Face Higher Death Risk From All Types of Breast Cancer
WEDNESDAY, Sept. 18, 2024 (HealthDay News) -- Black women have a higher risk of dying from any type of breast cancer than ...
14h
on MSN
Study confirms fibrosis as a prognostic indicator in the most common breast cancer
The most common breast cancer is HER2-negative, so called because it has low amounts of one of the proteins that contribute ...
2h
Senate president partners with UPMC, Bayer, others to host breast cancer screenings
Because Senate President Pro Tempore Kim Ward is a breast cancer survivor, she said she knows the importance of screening for ...
17h
on MSN
Making Strides Against Breast Cancer Walk returns to Union Station!
Ava Clay was diagnosed with breast cancer eight years ago. Clay had a small lump that would grow and shrink each month, and ...
NTV
55m
NMG launches breast cancer awareness run to promote screening
As Uganda joins the rest of the world in commemorating Cancer Month this September, Nation Media Group has partnered with ERIC Cancer Institute, Her Working Women, the First Lady’s Office, ...
14h
Former GOP leader, UM Regent Ron Weiser gives $25 million for new UM breast cancer center
The Weiser Family Center for Breast Cancer will help improve experiences by creating programs to support patients and expand ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Hina Khan
Black women
Novartis
Kisqali
Food and Drug Administration
Feedback